Novartis Pharmaceuticals Director of Operations Salaries in San Francisco
The average Novartis Pharmaceuticals Director of Operations in San Francisco earns an estimated $209,790 annually, which includes an estimated base salary of $173,586 with a $36,204 bonus. Novartis Pharmaceuticals' Director of Operations compensation is $69,024 more than the US average for a Director of Operations. Director of Operations salaries at Novartis Pharmaceuticals in San Francisco can range from $150,000 - $290,000.
In San Francisco, The Operations Department at Novartis Pharmaceuticals earns $12,953 more on average than the Customer Support Department.
Last updated 2 years ago.
- $173,586
- avg. base
- $36,204
- avg. bonus
Director of Operations Salaries at Novartis Pharmaceuticals
In San Francisco, Directors of Operations earn $1,995 more than Directors of Operations.
Compensation at Novartis Pharmaceuticals by Department
In San Francisco, The Operations Department averages $12,953 more than the Customer Support Department, and $5,379 less than the Business Development Department
Director of Operations Compensation by Gender (All Companies)
The average female Director of Operations at companies similar size to Novartis Pharmaceuticals reported making $178,169, while the average male Director of Operations at similar sized companies reported making $182,882.
Director of Operations Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Operations at companies similar size to Novartis Pharmaceuticals reported making $184,403, while the average African American/Black Director of Operations at similar sized companies reported making $141,003.
How Directors of Operations at Novartis Pharmaceuticals Rate Their Compensation
The majority of Directors of Operations at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Directors of Operations at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
